TiaLinx, an Irvine, California firm, is releasing a new product for radiation-free and non-contact breast tissue screening.The AR60-A device emits non-ionizing electromagnetic radiation, focusing the beam using special wafer-thin panels and detecting the response using planar antennas.
The technology takes advantage of the fact that different cell types have different electrical properties. The AR60-A spots abnormal cell clusters and highlights them on the screen against a blue background of normal cells.
TiaLinx plans to apply for FDA approval for the device, with the goal of submitting the application by the fourth quarter of 2015. Additionally, the product line will be spun-off into a separate new company called MamoMedix.
Press release: TiaLinx, Inc. Announces the Development of its AR60-A Scanner Technology to Detect Abnormal Breast Cell Clusters…